Clinical Trial Update: Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell [Phase 2]

View source ↗

Summary

This update describes a Phase 2 single-arm pilot trial of letermovir for cytomegalovirus prophylaxis in patients receiving CAR T-cell therapy, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Letermovir (letermovir)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cell Therapy | Phase 2 | Status: RECRUITING